SNL’s ‘Sister’ Sketch Made Me Laugh, Cry and Rage

Over the weekend, I watched Saturday Night Live‘s viral “Sister” sketch, and I wasn’t sure whether to laugh, cry, or feel rage. I ended up feeling all three.

For almost six years, I have been responsible for my mother’s care. Like the fictional Sister, I have a sibling, but the work has fallen to me, the oldest daughter.

As I watched John Mulaney jokingly promote “Sister,” a free service that allows men to leave the care of their aging parents to their sisters, I recognized so much of my own experience.

In the sketch, Mulaney says he no longer needs to worry about his father’s needs because his sister handles everything. “I can get back to my life and the stuff I like to do.” That line hit hard. Because when the work and constant worry of caregiving fall on one person—Sister—everyone else is free to live their lives and do what they enjoy.

November is National Family Caregivers Month, making the sketch particularly timely. Behind the laughter is a serious conversation about who cares for our aging parents, who gets to walk away and why that responsibility falls disproportionately on women.

The most revealing part of the sketch is when Mikey Day—playing Dr. Grant, author of the fictional Not It! A Son’s Guide to Elder Care—explains how it all works. “First, years of internalized sexism warps Sister’s brain into thinking caretaking is her responsibility and somehow not yours.”

There it is. The uncomfortable truth beneath the comedy.

The Real Cost of Trump’s ‘Big Beautiful Bill’ Is Just Beginning

In July 2025, Republicans in Congress passed, and President Donald Trump signed, this administration’s signature piece of legislation: the One Big Beautiful Bill Act (OBBBA).

In addition to directing unprecedented levels of funding toward the administration’s anti-immigrant detention and deportation agenda, the OBBBA slashed funding for programs that help people afford food, healthcare and education to pay for trillions of dollars in tax cuts that overwhelmingly benefit the wealthiest people and corporations.

And the worst is yet to come: The OBBBA was specifically designed to delay many of its harmful measures until after the November 2026 midterm elections—leaving millions of Americans bracing for the worst.

A Double Blow to Abortion Rights in Idaho: Prop 1 Fails at the Ballot Box, and a Federal Court Sides With the State

The elation that so many have been feeling in the wake of the midterms, has been tamped down in Idaho, as the result of two powerful and closely related reminders that the unremitting attacks on abortion rights are not going to let up any time soon.

First, on Oct. 30, a divided panel of the Ninth Circuit Court of Appeals issued an interim decision in the case of Seyb v. Idaho Board of Medical Examiners privileging Idaho’s “profound interest” in protecting fetal life over a pregnant woman’s right to self-preservation when faced with a health-threatening condition or the risk of death due to self-harm.

Then on Nov. 3,  in sharp contrast to the outcomes in the other three states where abortion was on the ballot, Proposition 1 failed to pass in Idaho, which would have legalized abortion until viability (with an extremely narrow emergency exception), which leaves one of the nation’s strictest criminal abortion bans in place.

A Pregnant Haitian Woman Faces an Uncertain Future After Trump Ends Temporary Protected Status: ‘I’m Sorry I’m Bringing Her Into This World’

Marie (a pseudonym) lay on the cold examination table again, watching as the doctor moved the ultrasound wand across her belly. Eight months pregnant, after suffering a miscarriage in August 2025, she was navigating a high-risk pregnancy complicated by avascular necrosis, a condition that eventually led to a double hip replacement.

Now, as she listened to her baby girl’s heartbeat, she couldn’t help but wonder whether the receptionist had frowned at her because she was having a bad day or because something in Marie’s file had made her consider calling U.S. Immigration and Customs Enforcement.

As I sat with Marie, I watched as she held back tears when she spoke about her daughter and the guilt she felt. “I feel so bad for her sometimes… I’m sorry that I’m bringing her into this world under these circumstances. It feels like somehow failing in life.”

Marie’s exhaustion is not unique within the Haitian community. Earlier this month, the community buried Pierre Damas Bel, a 20-year-old Haitian college student who died by suicide on Aug. 31 after losing TPS and being required to wear an ankle monitor by ICE.

I asked Marie what she hoped for her daughter. Rubbing her belly, she said, “I would love for her to grow up in a world where she’s not going to experience the things that I’m experiencing … Being a community organizer, I’ve seen change happen in my lifetime, so I know it is possible for things to change. Nothing can stay the same. I’m hopeful that the generation that we are in will help turn the boat around.”

With the Nov. 3 midterm elections approaching, voters have an opportunity to examine where candidates stand on Temporary Protected Status, immigration enforcement and access to healthcare for immigrant families.

These aren’t abstract policy debates for people like Marie. They’re questions of whether a mother can afford prenatal care, whether she can work to support her family and whether she can imagine a secure future for her daughter.

ACA Open Enrollment Starts Nov. 1 in Most States. Here’s What to Expect—Including Higher Premiums and New Hurdles

Consumers who buy Affordable Care Act health insurance are going to see changes both big and small, as open enrollment for 2027 coverage kicks off. These include premium increases, possible additional identity checks, potential delays in working with a broker and new limits on which immigrants can get subsidies.

Shoppers need to plan accordingly.

Open enrollment starts Nov. 1 in most states. Idaho, Connecticut and Massachusetts start earlier, and some states are already allowing “window shopping” to check premium rates.

A continued decline in overall enrollment is expected, mainly because of the expiration of enhanced subsidies at the end of 2025. Policy experts say the end of those subsidies led millions to drop or lose coverage through the first few months of this year.

But the Trump administration sees victory in the falling enrollment, crediting its various efforts to reduce fraud, including the August cancellation of policies covering 760,000 enrollees suspected to be improperly signed up. A small number of those enrollees have regained coverage.

How Abortion Bans Could Make Your IUD Insertion More Painful (And Other Far-Reaching Consequences)

In the fall of 2024, Louisiana implemented the nation’s first-ever law designating mifepristone and misoprostol as controlled substances. That put the pills in the same category as opioids and anxiety medi­cations that have a high risk of­ dependency and abuse, even though mifepristone and misoprostol have no recreational use, ­aren’t stimulants or sedatives, and are not addictive.

“They do not meet the definition or intent of what a controlled substance is, and categorizing them as such can lead to harm,” warned the American College of Medical Toxicology. “Additionally, it sets a dangerous ­precedent of politicizing phar­maceu­ti­cal regulation.”

The state targeted the two drugs ­because they are used in combination in most abortions. But mifepristone and misoprostol have a broad range of other medical uses beyond abortion—from inducing­ labor, to assisting in the removal of uterine polyps.

Dr. Emily Holt, a family medicine physician in New Orleans, had regularly prescribed both drugs to help patients manage miscarriages, and had offered just misoprostol to those with a stenotic cervix, in which the entrance to the uterus closes up. But she most frequently used misoprostol for IUD insertions.

Why This Menopause Expert Turned Down Trump’s Rose Garden Photo Op

On Monday, President Donald Trump and First Lady Melania Trump presided over a bizarre ceremony in the Rose Garden where she made rare public remarks and he signed an executive order, “Advancing Women’s Health to Improve Outcomes in All Phases of Life.”

Never mind that his executive order has the same primary objectives as one signed by President Joe Biden in 2024—namely, increased research in and knowledge about diseases and conditions that affect women uniquely or disproportionately. Both executive orders make explicit the need to focus on menopause, midlife and aging, with stated priorities such as Alzheimer’s Disease, cardiovascular and heart disease, stroke and osteoporosis.

The biggest difference between the two is that Biden’s tied dollar amounts to these objectives: Though the $12 billion he directed Congress to allocate never materialized, hundreds of millions were activated across several federal agencies.

Alas, that executive order is now officially replaced with the current one.

As much as I want to mean it when I say, This agenda must transcend partisanship, and I want to show up for the millions of women who deserve these hard-won milestones—it was way too large a leap to be in the room where this executive order happened.

Yes, I was invited to the Rose Garden. Yes, I declined.

Why Women Need a Hormonal Bill of Rights

For too long, midlife symptoms of women have been minimized; our concerns dismissed, our suffering normalized and our voices overlooked. We reject the notion that hormonal decline is simply something to endure.

Everyone has the right to connection, support, shared knowledge, honest conversation free from shame and community in search of quality of life.

To ask questions.
To demand answers.
To require equal research.
To expect better healthcare.
To defy patriarchal control.
To hormonally radicalize the world.

Restricting Mifepristone Access Could Empower Abusers

The 5th U.S. Circuit Court of Appeals heard arguments on Sept. 9 in Louisiana v. FDA, one of three cases threatening nationwide access to mifepristone, the medication used in the majority of abortions in the United States. 

While its stakes center on access to mifepristone generally, survivors of intimate partner violence (IPV) may be among the hardest hit by a national restriction on the abortion care drug.  

Already living under extreme, sometimes life-threatening, circumstances, survivors have vanishingly few options to care for themselves in the event of a pregnancy. Telehealth treatment and access to mifepristone by mail have been one of the few reprieves offered thus far, and their restriction could pose grave consequences to survivors nationwide.

You Deserve Better Menopause Care. Here’s How to Demand It.

“As women we have become way too comfortable with suffering,” said menopause expert Dr. Sharon Malone, MD, at a New York City book launch event for Jennifer Weiss-Wolf’s When in Menopause. “Menopause is just the last on the long train of suffering stops we’ve had.”

Weiss-Wolf’s new book makes the case for changing that, from demanding better care in the doctor’s office to fighting for policies that take women’s health seriously. As she put it during the conversation: “We’re saying we demand to be seen. We demand to be heard.”

In the following excerpt, Weiss-Wolf offers practical guidance for becoming your own best champion and receiving informed, respectful midlife healthcare.

When in Menopause: A User’s Manual and Citizen’s Guide is out Tuesday, Oct. 6, from Sheldon Press.